Mediclinic International PLC Company Profile (LON:MDC)

About Mediclinic International PLC (LON:MDC)

Mediclinic International PLC logoMediclinic International plc is an international private healthcare provider. The Company's segments include Mediclinic Southern Africa, Mediclinic Switzerland, Mediclinic Middle East, United Kingdom and Corporate. It focuses on providing acute care and multidisciplinary healthcare services. It has interest in Spire Healthcare, a United Kingdom-based private healthcare company. It has approximately 70 hospitals and over 40 clinics across its operating platforms. Mediclinic Southern Africa operates approximately 50 hospitals and over two day-clinics across South Africa, and over three hospitals in Namibia with approximately 8,000 in-patient beds. It has interest in Hirslanden AG, which operates over 20 private acute care facilities and approximately four clinics in Switzerland with over 1,600 in-patient beds. Mediclinic Middle East operates over five hospitals and approximately 40 clinics with over 600 in-patient beds in the United Arab Emirates.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: LON:MDC
  • CUSIP: N/A
  • Web: N/A
  • Market Cap: £5.99 billion
  • Outstanding Shares: 736,877,000
Average Prices:
  • 50 Day Moving Avg: GBX 788.06
  • 200 Day Moving Avg: GBX 771.41
  • 52 Week Range: GBX 666.50 - GBX 1,125
  • Trailing P/E Ratio: 29.38
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: £2.38 billion
  • Price / Sales: 2.52
  • Book Value: GBX 5.27 per share
  • Price / Book: 1.54
  • EBIDTA: £449 million
  • Average Volume: 1.50 million shs.

Frequently Asked Questions for Mediclinic International PLC (LON:MDC)

What is Mediclinic International PLC's stock symbol?

Mediclinic International PLC trades on the London Stock Exchange (LON) under the ticker symbol "MDC."

How often does Mediclinic International PLC pay dividends? What is the dividend yield for Mediclinic International PLC?

Mediclinic International PLC declared a dividend on Wednesday, May 24th. Investors of record on Thursday, June 22nd will be paid a dividend of GBX 4.70 per share on Monday, July 31st. This represents a yield of 0.58%. The ex-dividend date is Thursday, June 22nd. This is an increase from Mediclinic International PLC's previous dividend of $3.20. The official announcement can be seen at this link. View Mediclinic International PLC's Dividend History.

Where is Mediclinic International PLC's stock going? Where will Mediclinic International PLC's stock price be in 2017?

7 brokers have issued 1 year target prices for Mediclinic International PLC's stock. Their predictions range from GBX 658 to GBX 1,160. On average, they anticipate Mediclinic International PLC's stock price to reach GBX 852.17 in the next year. View Analyst Ratings for Mediclinic International PLC.

Who are some of Mediclinic International PLC's key competitors?

How do I buy Mediclinic International PLC stock?

Shares of Mediclinic International PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How much does a share of Mediclinic International PLC stock cost?

One share of Mediclinic International PLC stock can currently be purchased for approximately GBX 813.

Analyst Ratings

Consensus Ratings for Mediclinic International PLC (LON:MDC) (?)
Ratings Breakdown: 2 Sell Ratings, 3 Hold Ratings, 2 Buy Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: GBX 852.17

Analysts' Ratings History for Mediclinic International PLC (LON:MDC)
DateFirmActionRatingPrice TargetDetails
5/5/2017MacquarieBoost Price TargetNeutralGBX 760 -> GBX 790View Rating Details
4/28/2017InvestecReiterated RatingBuyView Rating Details
4/18/2017HSBC Holdings plcBoost Price TargetReduceGBX 640 -> GBX 660View Rating Details
4/11/2017Citigroup IncReiterated RatingNeutralView Rating Details
2/23/2017Credit Suisse Group AGLower Price TargetOutperformGBX 1,045 -> GBX 985View Rating Details
2/20/2017Jefferies Group LLCDowngradeUnderperformGBX 639 -> GBX 658View Rating Details
8/23/2016JPMorgan Chase & Co.Reiterated RatingNeutralGBX 1,160View Rating Details
5/11/2016Barclays PLCInitiated CoverageEqual weightGBX 905View Rating Details
5/6/2016Morgan StanleyInitiated CoverageEqual weightGBX 900View Rating Details
4/6/2016Charles StanleyReiterated RatingHoldView Rating Details
(Data available from 5/25/2015 forward)


Earnings History for Mediclinic International PLC (LON:MDC)
No earnings announcements for this company have been tracked by


Earnings Estimates for Mediclinic International PLC (LON:MDC)

No earnings estimates for this company have been tracked by


Dividend History by Quarter for Mediclinic International PLC (LON:MDC)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/24/2017GBX 4.700.58%6/22/20176/22/20177/31/2017
11/10/2016GBX 3.200.41%11/24/201611/24/201612/12/2016
5/25/2016GBX 5.240.61%6/16/20166/16/20167/25/2016
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Mediclinic International PLC (LON:MDC)
Insider Trades by Quarter for Mediclinic International PLC (LON:MDC)
Insider Trades by Quarter for Mediclinic International PLC (LON:MDC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/28/2016Alan GrieveInsiderBuy1,152GBX 734£8,455.68
(Data available from 1/1/2013 forward)


Headline Trends for Mediclinic International PLC (LON:MDC)
Latest Headlines for Mediclinic International PLC (LON:MDC)
DateHeadline logoMediclinic International PLC (MDC) Raises Dividend to GBX 4.70 Per Share - May 24 at 2:46 PM logoMediclinic yearly pretax profit rises 25% - May 24 at 10:53 AM logoMediclinic International PLC (MDC) Receives Consensus Recommendation of "Hold" from Analysts - May 19 at 7:31 PM logoMacquarie Raises Mediclinic International PLC (MDC) Price Target to GBX 790 - May 6 at 10:02 PM logoMediclinic International PLC's (MDC) Buy Rating Reiterated at Investec - April 29 at 6:14 PM logoMediclinic International Plc: Price momentum supported by strong fundamentals - April 28 at 7:23 PM logoIs Mediclinic International plc a screaming buy as shares surge 20% higher? - April 27 at 9:28 AM logoMediclinic International PLC (MDC) Given Consensus Rating of "Hold" by Analysts - April 24 at 8:02 PM logoMediclinic International Plc breached its 50 day moving average in a Bearish Manner : MDC-GB : April 19, 2017 - April 19 at 10:39 AM logoMediclinic International PLC (MDC) Price Target Raised to GBX 660 at HSBC Holdings plc - April 18 at 6:34 AM logoMacquarie Trims Mediclinic International PLC (MDC) Target Price to GBX 760 - April 17 at 3:06 AM logoMediclinic International PLC (MDC) Receives Neutral Rating from Citigroup Inc - April 17 at 3:06 AM logoMacquarie Cuts Mediclinic International PLC (MDC) Price Target to GBX 760 - April 15 at 12:27 PM logoMediclinic International PLC (MDC) Stock Rating Reaffirmed by Citigroup Inc - April 15 at 12:27 PM logoMediclinic 2017 trading in line with expectations - April 13 at 9:04 AM logoMediclinic International PLC (MDC) Downgraded by Macquarie to "Neutral" - April 8 at 7:59 PM logoMediclinic International PLC (MDC) Given Average Rating of "Hold" by Analysts - March 29 at 1:22 PM logoThese FTSE 100 stocks sank in Q4. Can they rebound in 2017? - January 3 at 10:57 AM


Social activity is not available for this stock.


Mediclinic International PLC (MDC) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by Staff